Aethlon Medical Statistics
Total Valuation
Aethlon Medical has a market cap or net worth of $2.65 million. The enterprise value is -$2.55 million.
Important Dates
The next estimated earnings date is Wednesday, February 11, 2026, after market close.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Aethlon Medical has 971,872 shares outstanding. The number of shares has increased by 191.00% in one year.
| Current Share Class | 971,872 |
| Shares Outstanding | 971,872 |
| Shares Change (YoY) | +191.00% |
| Shares Change (QoQ) | +91.44% |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 9.32% |
| Float | 754,515 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.09.
| Current Ratio | 4.45 |
| Quick Ratio | 4.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -701.20 |
Financial Efficiency
Return on equity (ROE) is -191.39% and return on invested capital (ROIC) is -67.61%.
| Return on Equity (ROE) | -191.39% |
| Return on Assets (ROA) | -54.79% |
| Return on Invested Capital (ROIC) | -67.61% |
| Return on Capital Employed (ROCE) | -119.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.23% in the last 52 weeks. The beta is 1.60, so Aethlon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -96.23% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 14.50 |
| Relative Strength Index (RSI) | 39.28 |
| Average Volume (20 Days) | 50,767 |
Short Selling Information
The latest short interest is 12,511, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 12,511 |
| Short Previous Month | 21,517 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 1.66% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.09M |
| Pretax Income | -11.26M |
| Net Income | -11.26M |
| EBITDA | -6.76M |
| EBIT | -7.09M |
| Earnings Per Share (EPS) | -$46.60 |
Full Income Statement Balance Sheet
The company has $5.85 million in cash and $542,411 in debt, with a net cash position of $5.31 million or $5.46 per share.
| Cash & Cash Equivalents | 5.85M |
| Total Debt | 542,411 |
| Net Cash | 5.31M |
| Net Cash Per Share | $5.46 |
| Equity (Book Value) | 5.75M |
| Book Value Per Share | 7.55 |
| Working Capital | 4.85M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -7.06M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.06M |
| FCF Per Share | -$7.26 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Aethlon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -191.00% |
| Shareholder Yield | -191.00% |
| Earnings Yield | -407.90% |
| FCF Yield | -255.68% |
Analyst Forecast
The average price target for Aethlon Medical is $287.50, which is 10,431.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $287.50 |
| Price Target Difference | 10,431.14% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -47.67% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |